{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:49:51Z","timestamp":1790844591153,"version":"4.1.0"},"reference-count":140,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["S006772N"],"award-info":[{"award-number":["S006772N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1800826\u00a0N"],"award-info":[{"award-number":["1800826\u00a0N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Kidney transplantation markedly improves survival and quality of life in patients with kidney failure, yet cardiovascular (CV) disease remains the leading cause of morbidity and mortality in kidney transplant recipients (KTRs). This review outlines the complex interplay of traditional, transplant-specific and recipient- and donor-related risk factors that sustain a high CV burden post-transplantation. While kidney function restoration reduces uremic toxins and improves cardiometabolic parameters, new challenges arise from immunosuppressive therapies, persistent hypertension, post-transplant diabetes mellitus and chronic inflammation. Common CV complications include coronary artery disease, heart failure, valvular disease, peripheral artery disease and refractory hypertension. Risk stratification tools and guidelines often fail to account for transplant-specific variables, resulting in suboptimal management. Although some pharmacological strategies and careful antihypertensive regimens show promise, most evidence is extrapolated from non-transplant populations due to the lack of dedicated randomized controlled trials. Emerging therapies like sodium-glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and non-steroidal mineralocorticoid receptor antagonists hold potential but require further validation in this population. Moreover, sex disparities persist in access to transplantation and in post-transplant outcomes, with men generally experiencing higher CV risk but women potentially facing greater relative mortality. The review underscores the urgent need for transplant-specific CV research, personalized therapeutic strategies including precision medicine and greater inclusion of women in research. Optimizing CV outcomes in KTRs will require multidisciplinary collaboration, rigorous evidence generation, and an integrated approach to risk prediction, prevention and treatment.<\/jats:p>","DOI":"10.1093\/ndt\/gfaf239","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:06:16Z","timestamp":1762671976000},"page":"998-1010","source":"Crossref","is-referenced-by-count":11,"title":["New kidneys, old risks: cardiovascular challenges after transplantation"],"prefix":"10.1093","volume":"41","author":[{"given":"Amaryllis H","family":"Van Craenenbroeck","sequence":"first","affiliation":[{"name":"University Hospitals Leuven Department of Nephrology, , Leuven ,","place":["Belgium"]},{"name":"Immunology and Transplantation, Nephrology and Renal Transplantation Research Group Department of Microbiology, , KU Leuven, Leuven ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9929-0567","authenticated-orcid":false,"given":"Shanmugakumar","family":"Chinnappa","sequence":"additional","affiliation":[{"name":"Doncaster and Bassetlaw Teaching Hospitals NHS Trust Department of Nephrology, , Doncaster ,","place":["UK"]},{"name":"Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), University of Leeds , Leeds ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-1829","authenticated-orcid":false,"given":"Evangelia","family":"Dounousi","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of Ioannina and University Hospital of Ioannina Nephrology Department, , Ioannina ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6727-1943","authenticated-orcid":false,"given":"Beatriz","family":"Fernandez-Fernandez","sequence":"additional","affiliation":[{"name":"2IIS-Fundacion Jimenez Diaz UAM , Madrid ,","place":["Spain"]},{"name":"School of Medicine, Universidad Aut\u00f3noma de Madrid Department of Medicine, , Madrid ,","place":["Spain"]},{"name":"RICORS2040 , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-227X","authenticated-orcid":false,"given":"Fotini","family":"Iatridi","sequence":"additional","affiliation":[{"name":"Hippokration Hospital, Aristotle University of Thessaloniki First Department of Nephrology, , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3387-2123","authenticated-orcid":false,"given":"Patrick B","family":"Mark","sequence":"additional","affiliation":[{"name":"School of Cardiovascular and Metabolic Health, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Renal and Transplant Unit, Queen Elizabeth University Hospital , Glasgow ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejc","family":"Piko","sequence":"additional","affiliation":[{"name":"Clinic for Internal Medicine, University Medical Centre Maribor Department of Dialysis, , Maribor ,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-8102","authenticated-orcid":false,"given":"Johannes","family":"Stegbauer","sequence":"additional","affiliation":[{"name":"Medical Faculty, University Hospital D\u00fcsseldorf, Heinrich-Heine-University D\u00fcsseldorf Department of Nephrology, , D\u00fcsseldorf ,","place":["Germany"]},{"name":"Cardiovascular Research Institute D\u00fcsseldorf, Medical Faculty, Heinrich Heine University ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Torino","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council, \u00a0 Reggio Calabria ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liffert","family":"Vogt","sequence":"additional","affiliation":[{"name":"Section of Nephrology Department of Internal Medicine, , Amsterdam ,","place":["The Netherlands"]},{"name":"Amsterdam Cardiovascular Sciences , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1343-0184","authenticated-orcid":false,"given":"Jose Manuel","family":"Valdivielso","sequence":"additional","affiliation":[{"name":"Vascular and Renal Translational Research Group, Institut de Recerca Biomedica de Lleida-Fundacion Dr Pifarre, IRBLleida , Lleida ,","place":["Spain"]},{"name":"RICORS2040 , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"2026052900265381200_bib1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"2026052900265381200_bib2","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib3","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/ndt\/gfz053","article-title":"Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies","volume":"34","author":"Rangaswami","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1053\/j.jrn.2012.01.022","article-title":"Metabolic disorders following kidney transplantation","volume":"22","author":"Phillips","year":"2012","journal-title":"J Ren Nutr"},{"key":"2026052900265381200_bib5","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1161\/01.CIR.0000034043.16664.96","article-title":"Sympathetic nerve activity in end-stage renal disease","volume":"106","author":"Hausberg","year":"2002","journal-title":"Circulation"},{"key":"2026052900265381200_bib6","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1093\/ndt\/gfu038","article-title":"Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study","volume":"29","author":"Betriu","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/14728222.2019.1620206","article-title":"An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients","volume":"23","author":"Bermudez-Lopez","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"2026052900265381200_bib8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/ATVBAHA.119.312705","article-title":"Atherosclerosis in chronic kidney disease: more, less, or just different?","volume":"39","author":"Valdivielso","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026052900265381200_bib9","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1111\/j.1600-6143.2004.00573.x","article-title":"Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib10","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/TP.0b013e318263ad5b","article-title":"Tobacco smoking and solid organ transplantation","volume":"94","author":"Corbett","year":"2012","journal-title":"Transplantation"},{"key":"2026052900265381200_bib11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nrneph.2016.187","article-title":"Physical inactivity: a risk factor and target for intervention in renal care","volume":"13","author":"Zelle","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2026052900265381200_bib12","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/TP.0000000000000085","article-title":"Pretransplant dialysis duration and risk of death after kidney transplantation in the current era","volume":"98","author":"Helanter\u00e4","year":"2014","journal-title":"Transplantation"},{"key":"2026052900265381200_bib13","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1161\/CIR.0000000000001104","article-title":"Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American Heart Association: endorsed by the American Society of Transplantation","volume":"146","author":"Cheng","year":"2022","journal-title":"Circulation"},{"key":"2026052900265381200_bib14","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"2026052900265381200_bib15","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/ndt\/gfaa131","article-title":"Impact of cardiovascular risk stratification strategies in kidney transplantation over time","volume":"35","author":"Deak","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib16","doi-asserted-by":"publisher","first-page":"e023548","DOI":"10.1161\/JAHA.121.023548","article-title":"Coronary revascularization versus optimal medical therapy in renal transplant candidates with coronary artery disease: a systematic review and meta-analysis","volume":"11","author":"Siddiqui","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026052900265381200_bib17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/diagnostics15070802","article-title":"From risk assessment to management: cardiovascular complications in pre- and post-kidney transplant recipients: a narrative review","volume":"15","author":"Beaudrey","year":"2025","journal-title":"Diagnostics"},{"issue":"Suppl 3","key":"2026052900265381200_bib18","doi-asserted-by":"publisher","first-page":"iii11","DOI":"10.1093\/ndt\/gfh1008","article-title":"The impact of donor age on the results of renal transplantation","volume":"19","author":"Oppenheimer","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib19","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1016\/j.transproceed.2012.09.086","article-title":"Cardiovascular risk in recipients with kidney transplants from expanded criteria donors","volume":"44","author":"Blanca","year":"2012","journal-title":"Transplant Proc"},{"key":"2026052900265381200_bib20","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/ajkd.2002.34927","article-title":"Patient survival after renal transplantation III: the effects of statins","volume":"40","author":"Cosio","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1053\/j.ackd.2010.10.006","article-title":"Hypertension following kidney transplantation","volume":"18","author":"Rubin","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026052900265381200_bib22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1046\/j.1600-6135.2003.00224.x","article-title":"Anemia: a continuing problem following kidney transplantation","volume":"3","author":"Mix","year":"2003","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1046\/j.1523-1755.2001.059002732.x","article-title":"Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years","volume":"59","author":"Cosio","year":"2001","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib24","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/j.1523-1755.2005.00349.x","article-title":"New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation","volume":"67","author":"Cosio","year":"2005","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib25","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s40620-023-01811-9","article-title":"Impact of timing of rejection episode on cardiovascular events in living donor kidney transplantation: a multicenter retrospective study","volume":"36","author":"Okamoto","year":"2023","journal-title":"J Nephrol"},{"key":"2026052900265381200_bib26","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0000000773","article-title":"Kidney allograft rejection as an independent non-traditional risk factor for post-transplant cardiovascular events","volume":"6","author":"Amornkanjanawat","year":"2025","journal-title":"Kidney360"},{"key":"2026052900265381200_bib27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.hjc.2018.07.002","article-title":"Coronary artery disease in renal transplant recipients: an angiographic study","volume":"61","author":"Paizis","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"2026052900265381200_bib28","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1111\/j.1600-6143.2005.00955.x","article-title":"Coronary artery calcification in renal transplant recipients","volume":"5","author":"Rosas","year":"2005","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib29","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1038\/s41598-019-43216-4","article-title":"Long-term evaluation of coronary artery calcifications in kidney transplanted patients: a follow up of 5 years","volume":"9","author":"Alfieri","year":"2019","journal-title":"Sci Rep"},{"key":"2026052900265381200_bib30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/ckj\/sfab174","article-title":"Coronary artery calcification progression and long-term cardiovascular outcomes in renal transplant recipients: an analysis by the joint model","volume":"15","author":"Seyahi","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026052900265381200_bib31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/jpm14070757","article-title":"Progression of coronary artery calcification according to changes in risk factors in asymptomatic individuals","volume":"14","author":"Yoo","year":"2024","journal-title":"J Pers Med"},{"key":"2026052900265381200_bib32","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1681\/ASN.2005090984","article-title":"Acute myocardial infarction and kidney transplantation","volume":"17","author":"Kasiske","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejim.2023.10.026","article-title":"Long-term cardiovascular events, graft failure, and mortality in kidney transplant recipients","volume":"121","author":"Andersson","year":"2024","journal-title":"Eur J Intern Med"},{"key":"2026052900265381200_bib34","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.2215\/CJN.00520121","article-title":"Post-transplant cardiovascular disease","volume":"16","author":"Birdwell","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900265381200_bib35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jacc.2004.11.061","article-title":"Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease","volume":"45","author":"Wali","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026052900265381200_bib36","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1097\/TXD.0000000000001647","article-title":"Left ventricular hypertrophy after renal transplantation: systematic review and meta-analysis","volume":"10","author":"Tian","year":"2024","journal-title":"Transplant Direct"},{"key":"2026052900265381200_bib37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5414\/CNP59079","article-title":"Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes","volume":"59","author":"Abbott","year":"2003","journal-title":"Clin Nephrol"},{"key":"2026052900265381200_bib39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.14740\/cr1092","article-title":"Transcatheter versus surgical aortic valve replacement in renal transplant patients: a meta-analysis","volume":"11","author":"Mir","year":"2020","journal-title":"Cardiol Res"},{"key":"2026052900265381200_bib40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.amjcard.2023.07.033","article-title":"A systematic review and meta-analysis of transcatheter versus surgical aortic valve replacement in kidney transplant patients","volume":"204","author":"Fong","year":"2023","journal-title":"Am J Cardiol"},{"key":"2026052900265381200_bib41","doi-asserted-by":"publisher","first-page":"14397","DOI":"10.1038\/s41598-017-14486-7","article-title":"Transfemoral transcatheter aortic valve implantation in patients with end-stage renal disease and kidney transplant recipients","volume":"7","author":"Al-Rashid","year":"2017","journal-title":"Sci Rep"},{"key":"2026052900265381200_bib42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/1358863X231205574","article-title":"Impact of preexisting coronary artery and peripheral artery disease on outcomes in diabetic patients after kidney transplant","volume":"29","author":"Jiwani","year":"2024","journal-title":"Vasc Med"},{"key":"2026052900265381200_bib43","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1681\/ASN.2006030201","article-title":"Peripheral arterial disease and renal transplantation","volume":"17","author":"Snyder","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib44","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/00007890-200010150-00010","article-title":"Peripheral vascular occlusive disease in renal transplant recipients: risk factors and impact on kidney allograft survival","volume":"70","author":"Sung","year":"2000","journal-title":"Transplantation"},{"key":"2026052900265381200_bib45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1358863X16689830","article-title":"Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients","volume":"22","author":"Patel","year":"2017","journal-title":"Vasc Med"},{"key":"2026052900265381200_bib46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and management of hypertension in transplant patients","volume":"26","author":"Weir","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib47","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1053\/j.ajkd.2004.03.013","article-title":"Hypertension after kidney transplantation","volume":"43","author":"Kasiske","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026052900265381200_bib49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1046\/j.1523-1755.1998.00744.x","article-title":"Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study","volume":"53","author":"Opelz","year":"1998","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/ckj\/sfab135","article-title":"Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis","volume":"15","author":"Pisano","year":"2022","journal-title":"Clin Kidney J"},{"key":"2026052900265381200_bib51","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1097\/HJH.0000000000000510","article-title":"Prevalence and clinical characteristics of renal transplant patients with true resistant hypertension","volume":"33","author":"Arias-Rodr\u00edguez","year":"2015","journal-title":"J Hypertens"},{"key":"2026052900265381200_bib52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1681\/ASN.0000000000000315","article-title":"Resistant hypertension in dialysis: epidemiology, diagnosis, and management","volume":"35","author":"Georgianos","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib53","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmed.2020.00229","article-title":"Approach and management of hypertension after kidney transplantation","volume":"7","author":"Tantisattamo","year":"2020","journal-title":"Front Med"},{"key":"2026052900265381200_bib54","doi-asserted-by":"publisher","first-page":"1360856","DOI":"10.3389\/fneph.2024.1360856","article-title":"Gender and kidney transplantation","volume":"4","author":"Nautiyal","year":"2024","journal-title":"Front Nephrol"},{"key":"2026052900265381200_bib55","doi-asserted-by":"publisher","first-page":"e39568","DOI":"10.1097\/MD.0000000000039568","article-title":"Gender differences in cardiovascular outcomes of kidney transplant recipients: a retrospective cohort study","volume":"103","author":"Liu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"2026052900265381200_bib56","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.kint.2022.05.017","article-title":"A population cohort analysis of English transplant centers indicates major adverse cardiovascular events after kidney transplantation","volume":"102","author":"Anderson","year":"2022","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib57","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.kint.2023.01.022","article-title":"A multinational cohort study uncovered sex differences in excess mortality after kidney transplant","volume":"103","author":"Vinson","year":"2023","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib58","doi-asserted-by":"publisher","first-page":"11206","DOI":"10.3389\/ti.2023.11206","article-title":"Representation of women in contemporary kidney transplant trials","volume":"36","author":"Vinson","year":"2023","journal-title":"Transpl Int"},{"key":"2026052900265381200_bib59","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1097\/TP.0000000000001002","article-title":"Survival benefit in renal transplantation despite high comorbidity","volume":"100","author":"S\u00f8rensen","year":"2016","journal-title":"Transplantation"},{"key":"2026052900265381200_bib60","article-title":"Exploring the Margins of Survival Benefit in Deceased Donor Kidney Transplantation: an International Target Trial Emulation","volume-title":"Presented at the ERA Congress 2025, 4\u20137 June 2025, Vienna, Austria","author":"Hellemans"},{"key":"2026052900265381200_bib61","doi-asserted-by":"publisher","first-page":"e1520","DOI":"10.1097\/TXD.0000000000001520","article-title":"Evolving trends in kidney transplant outcomes among older adults: a comparative analysis before and during the COVID-19 pandemic","volume":"9","author":"Li","year":"2023","journal-title":"Transplant Direct"},{"key":"2026052900265381200_bib62","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1097\/TP.0000000000003639","article-title":"Impact of pretransplant and new-onset diabetes after transplantation on the risk of major adverse cardiovascular events in kidney transplant recipients: a population-based cohort study","volume":"105","author":"Lim","year":"2021","journal-title":"Transplantation"},{"key":"2026052900265381200_bib63","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/TP.0000000000002440","article-title":"Pulse pressure and outcome in kidney transplantation: results from the Collaborative Transplant Study","volume":"103","author":"Kr\u00fcger","year":"2019","journal-title":"Transplantation"},{"key":"2026052900265381200_bib64","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40620-021-01143-6","article-title":"Association between early post-transplant hypertension or related antihypertensive use and prognosis of kidney transplant recipients: a nationwide observational study","volume":"34","author":"Park","year":"2021","journal-title":"J Nephrol"},{"key":"2026052900265381200_bib65","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1681\/ASN.0000000000000112","article-title":"Statins in kidney transplant recipients: usage, all-cause mortality, and interactions with maintenance immunosuppressive agents","volume":"34","author":"Bae","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib66","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib67","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"2026052900265381200_bib68","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.110.000588","article-title":"Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"123","author":"Bostom","year":"2011","journal-title":"Circulation"},{"key":"2026052900265381200_bib69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.ajkd.2005.05.014","article-title":"Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study","volume":"46","author":"Jardine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib70","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1681\/ASN.2013040435","article-title":"BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial","volume":"25","author":"Carpenter","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib71","doi-asserted-by":"publisher","first-page":"E438","DOI":"10.1111\/j.1399-0012.2012.01676.x","article-title":"Inadequacy of cardiovascular risk factor management in chronic kidney transplantation\u2014evidence from the FAVORIT study","volume":"26","author":"Carpenter","year":"2012","journal-title":"Clin Transplant"},{"key":"2026052900265381200_bib72","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0140-6736(11)61334-2","article-title":"Prevention of cardiovascular disease in adult recipients of kidney transplants","volume":"378","author":"Jardine","year":"2011","journal-title":"Lancet"},{"key":"2026052900265381200_bib73","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/tri.13322","article-title":"Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial","volume":"31","author":"van Dijk","year":"2018","journal-title":"Transpl Int"},{"key":"2026052900265381200_bib74","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.xkme.2022.100574","article-title":"Cardiovascular risk following conversion to belatacept from a calcineurin inhibitor in kidney transplant recipients: a randomized clinical trial","volume":"5","author":"Bredewold","year":"2023","journal-title":"Kidney Med"},{"key":"2026052900265381200_bib75","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1161\/CIRCULATIONAHA.118.038505","article-title":"Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients","volume":"139","author":"Rao","year":"2019","journal-title":"Circulation"},{"key":"2026052900265381200_bib76","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1053\/j.jrn.2023.07.001","article-title":"Nutrition in the management of kidney transplant recipients","volume":"33","author":"Stoler","year":"2023","journal-title":"J Ren Nutr"},{"key":"2026052900265381200_bib77","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41581-021-00428-0","article-title":"Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury","volume":"17","author":"Oellerich","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2026052900265381200_bib78","doi-asserted-by":"publisher","first-page":"l4923","DOI":"10.1136\/bmj.l4923","article-title":"Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study","volume":"366","author":"Loupy","year":"2019","journal-title":"BMJ"},{"key":"2026052900265381200_bib79","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2215\/CJN.0000000000000411","article-title":"Long-term outcomes after conversion to a belatacept-based immunosuppression in kidney transplant recipients","volume":"19","author":"Divard","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900265381200_bib80","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ndt\/gfv100","article-title":"Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR &lt;45\u00a0mL\/min)","volume":"30","author":"Guideline Development Group","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib81","doi-asserted-by":"publisher","first-page":"101627","DOI":"10.1016\/j.diabet.2025.101627","article-title":"Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus","volume":"51","author":"Diker Cohen","year":"2025","journal-title":"Diabetes Metab"},{"key":"2026052900265381200_bib82","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000005496","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists in kidney transplantation: a systematic review and meta-analysis","author":"Lee","year":"2025","journal-title":"Transplantation"},{"key":"2026052900265381200_bib83","doi-asserted-by":"publisher","first-page":"108604","DOI":"10.1016\/j.diabres.2020.108604","article-title":"Incretin based therapies and SGLT-2 inhibitors in kidney transplant recipients with diabetes: a systematic review and meta-analysis","volume":"172","author":"Oikonomaki","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2026052900265381200_bib84","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1093\/ndt\/gfaf104","article-title":"Lipid-lowering agents in solid organ transplant recipients","volume":"40","author":"Mickiewicz","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib85","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-6143.2005.01132.x","article-title":"Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation","volume":"6","author":"Kohnle","year":"2006","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib86","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/14740338.2020.1732921","article-title":"Treatment of dyslipidemia in kidney transplantation","volume":"19","author":"Ponticelli","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"2026052900265381200_bib87","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1097\/TP.0000000000004942","article-title":"Management of dyslipidemia with evolocumab in kidney transplant recipients","volume":"108","author":"Amaro","year":"2024","journal-title":"Transplantation"},{"key":"2026052900265381200_bib88","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1093\/ckj\/sfad007","article-title":"Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study","volume":"16","author":"S\u00e1nchez Fructuoso","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026052900265381200_bib89","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/j.ekir.2024.05.022","article-title":"Cardioprotective effect of SGLT2 inhibitor in diabetic kidney transplant recipients: a multicenter propensity score matched study","volume":"9","author":"Lim","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026052900265381200_bib90","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1038\/s41467-024-54171-8","article-title":"The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients","volume":"15","author":"Sheu","year":"2024","journal-title":"Nat Commun"},{"key":"2026052900265381200_bib91","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ekir.2025.01.007","article-title":"Is it time to expand the use of SGLT2 inhibitors in kidney transplant recipients?","volume":"10","author":"Giri","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026052900265381200_bib92","first-page":"gfaf046","article-title":"Rationale and design of the renal lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease","author":"Bakker","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib93","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ndt\/gfad258","article-title":"International consensus on post-transplantation diabetes mellitus","volume":"39","author":"Sharif","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib94","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1093\/ndt\/gfy065","article-title":"Mineralocorticoid receptor antagonists in kidney transplantation: time to consider?","volume":"33","author":"Girerd","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026052900265381200_bib95","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2215\/CJN.0000000000000439","article-title":"Effect of spironolactone on kidney function in kidney transplant recipients (the SPIREN trial): a randomized placebo-controlled clinical trial","volume":"19","author":"Mortensen","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900265381200_bib96","doi-asserted-by":"publisher","first-page":"sfae018","DOI":"10.1093\/ckj\/sfae018","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis","volume":"17","author":"Krisanapan","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026052900265381200_bib97","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S2213-8587(24)00371-1","article-title":"GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study","volume":"13","author":"Orandi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026052900265381200_bib98","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib99","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1053\/j.ajkd.2015.11.026","article-title":"Effects of dietary sodium restriction in kidney transplant recipients treated with renin-angiotensin-aldosterone system blockade: a randomized clinical trial","volume":"67","author":"de Vries","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib100","doi-asserted-by":"publisher","first-page":"100859","DOI":"10.1016\/j.trre.2024.100859","article-title":"A holistic review of sodium intake in kidney transplant patients: more questions than answers","volume":"38","author":"Afsar","year":"2024","journal-title":"Transplant Rev (Orlando)"},{"key":"2026052900265381200_bib101","doi-asserted-by":"publisher","first-page":"ii15","DOI":"10.1093\/ckj\/sfab022","article-title":"Exercise training in patients after kidney transplantation","volume":"14","author":"De Smet","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026052900265381200_bib102","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1053\/j.ajkd.2014.07.015","article-title":"Effect of exercise training on estimated GFR, vascular health, and cardiorespiratory fitness in patients with CKD: a pilot randomized controlled trial","volume":"65","author":"Greenwood","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib103","doi-asserted-by":"publisher","first-page":"100854","DOI":"10.1016\/j.trre.2024.100854","article-title":"Impact of donor smoking history on kidney transplant recipient outcomes: a systematic review and meta-analysis","volume":"38","author":"Rampersad","year":"2024","journal-title":"Transplant Rev (Orlando)"},{"key":"2026052900265381200_bib104","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/ajt.14707","article-title":"Dietary Approach to Stop Hypertension (DASH) diet and risk of renal function decline and all-cause mortality in renal transplant recipients","volume":"18","author":"Ost\u00e9","year":"2018","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib105","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.transproceed.2019.12.055","article-title":"Nutrition trends in patients over the long term after kidney transplantation","volume":"52","author":"Kluch","year":"2020","journal-title":"Transplant Proc"},{"key":"2026052900265381200_bib106","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MOT.0b013e3283560a3b","article-title":"Prevention of cardiovascular disease after renal transplantation","volume":"17","author":"Svensson","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"2026052900265381200_bib107","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40620-018-0549-4","article-title":"Cardiovascular risk in renal transplant recipients","volume":"32","author":"Devine","year":"2019","journal-title":"J Nephrol"},{"key":"2026052900265381200_bib108","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1111\/ajt.14665","article-title":"Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation","volume":"18","author":"Wissing","year":"2018","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib109","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet"},{"key":"2026052900265381200_bib110","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib111","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib112","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1056\/NEJMoa2409183","article-title":"Long-term effects of empagliflozin in patients with chronic kidney disease","volume":"392","author":"EMPA-KIDNEY Collaborative Group","year":"2025","journal-title":"N Engl J Med"},{"key":"2026052900265381200_bib113","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"The EMPA-KIDNEY Collaborative Group","year":"2023","journal-title":"N Engl J Med"},{"key":"2026052900265381200_bib114","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"2026052900265381200_bib115","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"2026052900265381200_bib116","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/TP.0000000000003224","article-title":"Cardiac mortality in kidney transplant patients: a population-based cohort study 1988-2013 in Australia and New Zealand","volume":"105","author":"Wyld","year":"2021","journal-title":"Transplantation"},{"key":"2026052900265381200_bib117","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1089\/jwh.2020.8594","article-title":"Sex differences in subclinical cardiovascular organ damage after renal transplantation: a single-center cohort study","volume":"30","author":"Stocklassa","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"2026052900265381200_bib118","doi-asserted-by":"publisher","first-page":"sfae044","DOI":"10.1093\/ckj\/sfae044","article-title":"Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease","volume":"17","author":"Balafa","year":"2024","journal-title":"Clin Kidney J"},{"key":"2026052900265381200_bib119","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1093\/eurheartj\/ehae504","article-title":"What is the role of sex and gender in the future of precision cardiology?","volume":"45","author":"Ministrini","year":"2024","journal-title":"Eur Heart J"},{"key":"2026052900265381200_bib120","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S0140-6736(22)01483-0","article-title":"Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation","volume":"400","author":"Wenzl","year":"2022","journal-title":"Lancet"},{"key":"2026052900265381200_bib121","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/ajt.15191","article-title":"Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients","volume":"19","author":"Pihlstr\u00f8m","year":"2019","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib122","doi-asserted-by":"publisher","first-page":"822","DOI":"10.2215\/CJN.00030108","article-title":"Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited","volume":"3","author":"Kiberd","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026052900265381200_bib123","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","article-title":"Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study","volume":"10","author":"Israni","year":"2010","journal-title":"Am J Transplant"},{"key":"2026052900265381200_bib124","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/TP.0b013e3182516cdc","article-title":"A cardiovascular risk calculator for renal transplant recipients","volume":"94","author":"Soveri","year":"2012","journal-title":"Transplantation"},{"key":"2026052900265381200_bib125","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3390\/jcm13102734","article-title":"Post-transplant cardiovascular disease in kidney transplant recipients: incidence, risk factors, and outcomes in the era of modern immunosuppression","volume":"13","author":"Chukwu","year":"2024","journal-title":"J Clin Med"},{"key":"2026052900265381200_bib126","doi-asserted-by":"publisher","first-page":"e240427","DOI":"10.1001\/jamanetworkopen.2024.0427","article-title":"Representation of patients with chronic kidney disease in clinical trials of cardiovascular disease medications: a systematic review","volume":"7","author":"Colombijn","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026052900265381200_bib127","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1681\/ASN.2016121380","article-title":"Association of sex with risk of kidney graft failure differs by age","volume":"28","author":"Lepeytre","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2026052900265381200_bib128","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib129","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1053\/j.ajkd.2021.09.013","article-title":"KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD","volume":"79","author":"Drawz","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib130","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2026052900265381200_bib131","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026052900265381200_bib132","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","article-title":"Renal association clinical practice guideline in post-operative care in the kidney transplant recipient","volume":"18","author":"Baker","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026052900265381200_bib133","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"2026052900265381200_bib134","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"2026052900265381200_bib135","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib136","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1053\/j.ajkd.2021.09.010","article-title":"KDOQI US commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD","volume":"79","author":"Mottl","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib137","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"2026052900265381200_bib138","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"2026052900265381200_bib139","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/j.ajkd.2014.10.005","article-title":"KDOQI US commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD","volume":"65","author":"Sarnak","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2026052900265381200_bib140","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfaf239\/65236932\/gfaf239.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/6\/998\/65236932\/gfaf239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/6\/998\/65236932\/gfaf239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:26:59Z","timestamp":1780028819000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/6\/998\/8316146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":140,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,11,6]]},"published-print":{"date-parts":[[2026,5,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfaf239","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2025,11,6]]}}}